Oklahoma City, Oklahoma
Locations:
Min Investment:
Max Investment:
Target Investment:
Certificate of Completion: Executive Education
Leadership, Policy Innovation & Geopolitics in Asia Pacific
(2017 - 2017)
Executive Education, "Leading through Change"
(2018 - 2018)
2024
2024
2020
2020
2014
2014
Sensulin is developing a glucose-responsive insulin for treatment of type I/II diabetes, which aims to make basal and prandial (mealtime) insulin obsolete, and eliminate the need for regular monitoring, thus giving insulin-dependent patients a chance at a normal life.
2017
2022
2022
Grand Founders is a New York-based foundation that supports economic development globally through its impact investments into emerging entrepreneurs, ensuring a noble legacy for generations to come. As a Board Member, I’ve committed to helping Grand Founders establish financial, social, and professional legacies across emerging economies while upholding the strictest adherence to good governance principles.
2005 - 2009
2005 - 2009
Charlesson is an Oklahoma-based pharmaceutical company, which operates EyeCRO, a specialty ocular CRO. The company develops therapeutics for eye diseases, including pharmaceutical treatments for Age-Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammation, and Glaucoma.
2005 - 2007
2005 - 2007
Atomic Venture Partners is an early stage venture capital fund with offices in the Silicon Valley, Boston, and OKC. AVP invests in early stage companies that leverage cutting-edge technology for “game-changing” results - which address very large potential markets and have compelling high margin business models. We add significant value beyond the capital that we invest: AVP is led by successful venture-backed entrepreneurs and technology executives, who have founded several best-of-breed companies in our target industries. This provides to entrepreneurs an intimate understanding of our chosen industries, the ability to provide a vast network, and an invaluable operational skill set for explosive growth. The Fund invests in the following areas: Semiconductors; Pharmaceuticals; Digital Media; and Nanotechnology.
2004 - 2007
2004 - 2007
Worked with Arrowhead Research to start NanoPolaris, which eventually became Unidym and acquired Carbon Nanotechnologies, Inc. Unidym was acquired in January 2011 for $145M in total value.
2001 - 2004
2001 - 2004
Founded SWeNT, a manufacturer of single-walled carbon nanotubes, with technology from ConocoPhillips & the University of Oklahoma. The company grew from $0 to over $1.1M in revenue within my first 12 months. ConocoPhillips and a major global semiconductor company were investors/partners in the company. I left after 3 years, upon hiring a stellar CEO.
2000 - 2002
2000 - 2002
Along with 3 other partners, licensed and developed technology from University of Sherbrooke, Quebec. NSTI manufactured nanoparticle titanium dioxide (TiO2) and other metal oxides for a variety of applications. Led the company's acquisition by DuPont in June 2002.